Human T cell lymphotropic virus type I tax activates IL-15Rα gene expression through an NF-κB site

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2602-2609

  Mariner, J M ^a   Lantz, V ^a   Waldmann, T A ^a   Azimi, N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15 RECEPTOR; MESSENGER RNA; TAX PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROMOTER REGION; VIRUS CELL INTERACTION;

EID: 0035865195     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2602     Document Type: Article

References (55)

1. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
2. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor
3. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
4. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15
5. Interleukin-2, interleukin-15, and their receptors
6. IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels
7. Characterization of interleukin-15 (IL-15) and the 1L- 15 receptor complex
8. Interleukin 15: What it does and how it is controlled
9. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor
10. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor
11. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
12. Deregulated T cell activation and autoimmunity in mice lacking IL-2 receptor β
13. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment
14. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
15. Biochemical mechanisms of IL-2 regulated Fas-mediated T cell apoptosis
16. Functional responses and apoptosis of CD25 (IL-2R α)-deficient T cells expressing a transgenic antigen receptor
17. + memory T cells by opposing cytokines
18. Interleukin-15 protects from lethal apoptosis in vivo
19. + T cells in vivo by IL-15
20. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells
21. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host cell response to intracellular pathogens
22. Functional characterization of the human interleukin 15 receptor α chain and close linkage of IL-I5RA and IL-2RA genes
23. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
24. Two cases of T-cell chronic lymphocytic leukemia in Japan
25. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
26. ATL and HTLV-I related diseases
27. Chronic progressive myelopathy associated with elevated antibodies to human T lymphotropic virus type I and adult T-cell leukemia-like cells
28. HTLV-I associated myelopathy (HAM), treatment trails, retrospective survey, and clinical and laboratory findings
29. Neurologic manifestations of infection with human T cell lymphotropic virus type I
30. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site
31. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15R receptor
32. x-responsive 21 base pair sequence
33. x encoded by human T cell leukemia virus type I
34. x and T3/T1 complex triggering
35. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy
36. 1 protein of human T-cell leukemia virus type I
37. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB
38. Structure, regulation and function of NF- κB
39. The inducible transcription factor NF-κB: Structure function relationship of its protein subunits
40. NF-κB and Rel: Participants in a multiform transcriptional regulatory system
41. Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic parapaesis
42. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I associated myelopathy
43. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia
44. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis
45. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
46. Evidence in support of a role for human T cell leukemia virus type 1 tax in activating NF-κB via stimulation of signaling pathways
47. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α
48. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation
49. A high proportion of early response genes are constitutively activated in T cells by HTLV-I
50. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells
51. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB
52. Multichain interleukin-2 receptor: A target for immunotherapy in lymphoma
53. + cytotoxic T-lymphocytes specific for HTLV-I pX in patients with HTLV-I-associated neurological disease
54. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions
55. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice